실시간 바이오 인텔리전스 · ADC · CGT

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

8,429+프로그램
44+FDA 승인
3,742+모집 중
ADC 1032·Antibody 4684·CGT 2713차세대 추천 →·Data Tier →
8429프로그램44FDA 승인
1,081오늘 방문
22,806누적 방문
7880갱신 대기S–CData TierS/A/B차세대→Insight1032HER2 breast4684Antibody2713CGT→Psoriasis→NSCLC44FDA 승인
피드Data Tier차세대Insight

추천 비교

비교 도구 →
HER2 ADCEnhertu · Kadcyla · RC48CD19 CAR-TYescarta · KymriahPD-1Keytruda · Opdivo다발골수종Darzalex · BlenrepTROP2 ADCTrodelvy · Dato-DXd · SGNectin-4 · TROP2Padcev · Trodelvy건선 IL pathwayStelara · Cosentyx · SkyriziAnti-VEGF (안과)Eylea · LucentisAnti-TNFHumira · EnbrelIL-12/23Stelara · Skyrizi아토피·IL-13Dupixent · EbglyssPCSK9 · LDLRepatha · Praluent · LeqvioGLP-1 · incretinSemaglutide · Tirzepatide혈우병 유전자치료Hemgenix · Roctavian겸상적혈구 CGTCasgevy · Lyfgenia망막·DMD 유전자치료Luxturna · Elevidys

빠른 검색 · 이슈 태그

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 3,531개
다음 갱신 D-13 · 마지막 7월 31일
CGTBiologicstaleBeijing Immunochina Medical Sci…Phase 1

Engineering of chimeric antigen receptors targeting CD19 in allogeneic T cells (Engineering of chimeric antigen receptors targeting CD19 in allogeneic T cells)

Difficult to Treat Systemic Lupus Erythematosus · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
ADCBiologicstaleRemeGen Co., Ltd.Govitecan in Untreated, Adv…Phase 2

Albumin-bound Paclitaxone (Albumin-bound Paclitaxone)

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleSeagen, a wholly owned subsidia…Phase 1

Felmetatug Vedotin (Felmetatug Vedotin)

Ovarian Neoplasms; Peritoneal Neoplasms · HER2

#HER2#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 DISCONTINUED
AntibodystaleIRCCS National Neurological Ins…Preclinical

MAbs (MAbs)

Migraine Disorders; Chronic Migraine · Migraine Disorders

#MigraineDisorders#Antibody#Preclinical#항체#면역항체+3
임상시험 1상태 RECRUITING
ADCCFDAFDABiologicFDA approved (openFDA)Approved

TELISOTUZUMAB VEDOTIN-TLLV (TELISOTUZUMAB VEDOTIN-TLLV)

FDA-approved indication · See label

#Seelabel#ADC#Approved#FDA승인#항체약물접합체+3
임상시험 0상태 APPROVED
ADCCFDAFDABiologicFDA approved (openFDA)Approved

DATOPOTAMAB DERUXTECAN-DLNK (DATOPOTAMAB DERUXTECAN-DLNK)

FDA-approved indication · See label

#Seelabel#ADC#Approved#FDA승인#항체약물접합체+3
임상시험 0상태 APPROVED

142 / 142 페이지

← 이전다음 →
전체 8,429개 프로그램 보기